Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Neurofibromatoses

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Neurofibromatoses:

Pubmed Logo
The neurofibromatoses. Part 2: NF2 and schwannomatosis.
The neurofibromatoses, including neurofibromatosis 1 (NF1),...
10th November, 2009
Department of Neurology, University of Washington, Seattle, WA, USA. Rev Neurol Dis. 2009 Summer;6(3):E81-6.
The Neurofibromatoses. Part 1: NF1.
The neurofibromatoses, including neurofibromatosis 1 (NF1),...
10th October, 2009
Department of Neurology, University of Washington, Seattle, WA, USA. Rev Neurol Dis. 2009 Spring;6(2):E47-53.
Neurofibromatosis: advances in molecular genetics, diagnosis, and treatment. Introduction.
The neurofibromatoses, including neurofibromatosis 1 (NF1),...
10th October, 2009
New York University School of Medicine, New York, NY, USA. Rev Neurol Dis. 2009 Spring;6(2):E45-6.
Ras signaling and therapies.
More than 25 years have passed since activating mutations in Ras genes...
23rd September, 2009
UCSF Helen Diller Family Comprehensive Cancer Center and Cancer Research Adv Cancer Res. 2009;102:1-17.
DOI Direct Link
Risks of radiation therapy in patients with neurofibromatosis.
The neurofibromatoses, including neurofibromatosis 1 (NF1),...
22nd September, 2009
Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):632.
DOI Direct Link

View more research publications.

Neurofibromatoses Clinical Trials:

Clinical Trials Logo
Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)

Neurofibromatoses Patents:

USPTO Logo
US Patent No.Title
7595192 Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds
6973388 Methods of diagnosing disease states using gene expression profiles
6660477 Method for the determination of data for the preparation of the diagnosis of phakomatosis
6218122 Methods of monitoring disease states and therapies using gene expression profiles
5693779 Production and use of anti-dorsalizing morphogenetic protein

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Neurofibromatoses scientists - we have details of around 139 individuals working on Neurofibromatoses .


This page has been viewed 412 times
Recent Search Terms used to find this page: seattle clinical trials nf1 | propolis neurofibromatose | neurofibromatose | propolis neurofibromatose | propolis neurofibromatose | propolis neurofibromatose | propolis neurofibromatose | propolis et neurofibromatose | PAK 1 neurofibromatose | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Neurofibromatoses across BioPortfolio, or for Neurofibromatoses Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.